Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Five Below Inc (FIVE) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Five Below IncTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Five Below Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Five Below Inc trades at $234.75 (market cap $12.95B), while State Street SPDR S&P Biotech ETF trades at $159.3. Which is the better fit depends on your goals.

FIVEXBI
Market Cap
$12.95B
Sector
Consumer StaplesBroad Market / Factor
52-Week High
$247.71$164.28
52-Week Low
$134.36$86.92
Enterprise Value
$13.84B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Five Below Inc

Five Below (FIVE) trades at $235.36, down 3.69% on the day but maintains strong technical momentum with bullish moving averages. The company demonstrates consistent revenue growth, reaching $3.88B in 2025, and has beaten earnings estimates in three consecutive quarters. Analyst sentiment remains overwhelmingly positive with 31 buy ratings and a $256.45 consensus price target, representing 9% upside potential from current levels.

FIVE presents a compelling growth story with expanding store footprint and product innovation driving sales. Key risks include consumer spending sensitivity and competitive retail pressures. The stock's premium valuation (P/E 29.53) requires continued execution, but strong institutional interest and positive earnings momentum support the bullish case for long-term investors.

State Street SPDR S&P Biotech ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Five Below Inc

Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics

Read more on FIVE

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI